telmisartan has been researched along with 2019 Novel Coronavirus Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delic, D; Gaballa, MMS; Hasan, AA; Hocher, B; Klein, T; Kleuser, B; Krämer, BK; Li, J; Liu, L; Xie, L; Xiong, Y; Zhang, X | 1 |
| Chen, D; DiCostanzo, JR; Donini, O; Lee, D; Lehrer, AT; Shikuma, CM; Shimoda, L; Suk, JS; Thompson, K; Yun, X | 1 |
| Belal, F; Elkhoudary, MM; Hadad, GM; Radwan, AS; Salim, MM | 1 |
| Duarte, M; Ignacio, FC; Nicolosi, L; Pelorosso, FG; Rothlin, RP; Salgado, MV; Vetulli, H | 1 |
| Duarte, M; Pelorosso, FG; Rothlin, RP; Vetulli, HM | 1 |
| Banerji, S; Mehrpour, O; Nakhaee, S; Shirazi, FM | 1 |
| Hasan, SS; Kow, CS | 1 |
| Anglaret, X; Binquet, C; Bouchet, S; Crémer, A; Darnaud, T; Dupouy, J; Duvignaud, A; Gimbert, A; Joseph, JP; Journot, V; Lebeaux, D; Lebel, J; Lefèvre, B; Lhomme, E; Malvy, D; Michel, JF; Nguyen, D; Onaisi, R; Orne-Gliemann, J; Peiffer-Smadja, N; Piroth, L; Pistone, T; Poitrenaud, D; Richert, L; Roussillon, C; Sitta, R; Thiébaut, R; Wittkop, L | 1 |
| Advani, A; Advani, SL; Batchu, SN; Kabir, MG; Kaur, H; Klein, T; Liu, Y; Yerra, VG | 1 |
| Choi, J; Ihm, SH; Kim, JY; Kwon, SU; Lee, HY; Park, SH; Park, SW; Sung, KC; Yoon, CH | 1 |
2 trial(s) available for telmisartan and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to R
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Tolerance; Feasibility Studies; France; Hospitalization; Humans; Hydroxychloroquine; Imatinib Mesylate; Luxembourg; Outpatients; Pandemics; Pneumonia, Viral; Protein Kinase Inhibitors; Pyrazines; Risk Reduction Behavior; SARS-CoV-2; Telmisartan; Therapies, Investigational; Treatment Outcome | 2020 |
Central blood pressure lowering effect of telmisartan-rosuvastatin single-pill combination in hypertensive patients combined with dyslipidemia: A pilot study.
Topics: Ankle Brachial Index; Antihypertensive Agents; Benzoates; Blood Pressure; COVID-19; Drug Combinations; Dyslipidemias; Humans; Hypertension; Pandemics; Pilot Projects; Prospective Studies; Pulse Wave Analysis; Rosuvastatin Calcium; SARS-CoV-2; Telmisartan | 2021 |
8 other study(ies) available for telmisartan and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Impact of Salt Intake and Renin-Angiotensin-Aldosterone System Blockade on Lung Severe Acute Respiratory Syndrome Coronavirus 2 Host Factors.
Topics: Angiotensin-Converting Enzyme 2; Animals; COVID-19; Enalapril; Lung; Rats; Renin-Angiotensin System; RNA, Messenger; SARS-CoV-2; Serine Endopeptidases; Sodium Chloride, Dietary; Telmisartan | 2022 |
Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory Infections.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; COVID-19; Renin-Angiotensin System; Respiratory Tract Infections; SARS-CoV-2; Telmisartan | 2023 |
Green fluorometric strategy for simultaneous determination of the antihypertensive drug telmisartan (A tentative therapeutic for COVID-19) with Nebivolol in human plasma.
Topics: Antihypertensive Agents; COVID-19; Humans; Nebivolol; Pharmaceutical Preparations; Telmisartan | 2023 |
Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19.
Topics: Antihypertensive Agents; COVID-19; Humans; Hypertension; Losartan; Telmisartan | 2023 |
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Clinical Trials, Phase II as Topic; COVID-19; COVID-19 Drug Treatment; Humans; Lung; Pandemics; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Telmisartan; Virus Internalization | 2020 |
Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Host-Pathogen Interactions; Humans; Losartan; Pandemics; Pneumonia, Viral; Prognosis; SARS-CoV-2; Severity of Illness Index; Telmisartan; Tomography, X-Ray Computed; Valsartan | 2020 |
The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Mice; Overweight; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Rats; SARS-CoV-2; Telmisartan | 2020 |
Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker-Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19.
Topics: Age Factors; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; COVID-19; Diabetes Mellitus, Experimental; Diet, High-Fat; Immunoblotting; In Situ Hybridization; Kidney; Lung; Male; Mice; Ramipril; Receptors, Coronavirus; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Serine Endopeptidases; Telmisartan | 2021 |